Commodities: VP Doberstein Sells 100,000 Of Nektar Therapeutics >NKTR

SOURCE: Form 4 
ISSUER: Nektar Therapeutics 
FILER: Doberstein Stephen K 
TITLE: Vice President 
DATE               TRANSACTION              SHARES       PRICE           VALUE 
4/5/17             Exercise*               100,000       $9.53        $953,000 
4/5/17             Sale                    100,000      $21.70      $2,170,000 
(10b5-1 Plan Indicated)** 
OWNERSHIP: 34,504 (Direct) 
  * - Exercised 3 years, 2 months after vesting and 9 months, 2 days before 
 ** - A 10b5-1 plan enables an insider to establish a program to make trans- 
      actions according to an advance plan.  Such a program allows an insider 
      to continue with planned transactions even if he or she comes into 
      possession of material non-public information. 
  The Form 4 is filed with the Securities and Exchange Commission by insiders 
  to report transactions in their companies' shares.  Open market purchases 
  and sales must be reported within two business days of the transaction. 
Insider Data Source: The Washington Service 
                     ([email protected] or 301-913-5100)